This report contains market size and forecasts of Brain Tumor Therapeutics in Global, including the following market information:
Global Brain Tumor Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Brain Tumor Therapeutics market was valued at 1144.6 million in 2020 and is projected to reach US$ 1672.9 million by 2027, at a CAGR of 10.0% during the forecast period.
Publisher has surveyed the Brain Tumor Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Tumor Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Brain Tumor Therapeutics Market Segment Percentages, By Type, 2020 (%)
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Immunotherapy
China Brain Tumor Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Brain Tumor Therapeutics Market Segment Percentages, By Application, 2020 (%)
Hospitals
Oncology Treatment Centers
Others
Global Brain Tumor Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Brain Tumor Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Brain Tumor Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Brain Tumor Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Pfizer
Novartis
Roche
Merck
AstraZeneca
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
DelMar Pharmaceuticals
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Brain Tumor Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brain Tumor Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Brain Tumor Therapeutics Overall Market Size
2.1 Global Brain Tumor Therapeutics Market Size: 2021 VS 2027
2.2 Global Brain Tumor Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Brain Tumor Therapeutics Players in Global Market
3.2 Top Global Brain Tumor Therapeutics Companies Ranked by Revenue
3.3 Global Brain Tumor Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Brain Tumor Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Brain Tumor Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Tumor Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Brain Tumor Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Brain Tumor Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Brain Tumor Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Surgery
4.1.3 Radiation Therapy
4.1.4 Targeted Therapy
4.1.5 Chemotherapy
4.1.6 Immunotherapy
4.2 By Type - Global Brain Tumor Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Brain Tumor Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Brain Tumor Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Brain Tumor Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Brain Tumor Therapeutics Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Oncology Treatment Centers
5.1.4 Others
5.2 By Application - Global Brain Tumor Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Brain Tumor Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Brain Tumor Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Brain Tumor Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Brain Tumor Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Brain Tumor Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Brain Tumor Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Brain Tumor Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Brain Tumor Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Brain Tumor Therapeutics Revenue, 2016-2027
6.3.2 US Brain Tumor Therapeutics Market Size, 2016-2027
6.3.3 Canada Brain Tumor Therapeutics Market Size, 2016-2027
6.3.4 Mexico Brain Tumor Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Brain Tumor Therapeutics Revenue, 2016-2027
6.4.2 Germany Brain Tumor Therapeutics Market Size, 2016-2027
6.4.3 France Brain Tumor Therapeutics Market Size, 2016-2027
6.4.4 U.K. Brain Tumor Therapeutics Market Size, 2016-2027
6.4.5 Italy Brain Tumor Therapeutics Market Size, 2016-2027
6.4.6 Russia Brain Tumor Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Brain Tumor Therapeutics Market Size, 2016-2027
6.4.8 Benelux Brain Tumor Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Brain Tumor Therapeutics Revenue, 2016-2027
6.5.2 China Brain Tumor Therapeutics Market Size, 2016-2027
6.5.3 Japan Brain Tumor Therapeutics Market Size, 2016-2027
6.5.4 South Korea Brain Tumor Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Brain Tumor Therapeutics Market Size, 2016-2027
6.5.6 India Brain Tumor Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Brain Tumor Therapeutics Revenue, 2016-2027
6.6.2 Brazil Brain Tumor Therapeutics Market Size, 2016-2027
6.6.3 Argentina Brain Tumor Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Brain Tumor Therapeutics Revenue, 2016-2027
6.7.2 Turkey Brain Tumor Therapeutics Market Size, 2016-2027
6.7.3 Israel Brain Tumor Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Brain Tumor Therapeutics Market Size, 2016-2027
6.7.5 UAE Brain Tumor Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Brain Tumor Therapeutics Major Product Offerings
7.1.4 Pfizer Brain Tumor Therapeutics Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Brain Tumor Therapeutics Major Product Offerings
7.2.4 Novartis Brain Tumor Therapeutics Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Brain Tumor Therapeutics Major Product Offerings
7.3.4 Roche Brain Tumor Therapeutics Revenue in Global (2016-2021)
7.3.5 Roche Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Brain Tumor Therapeutics Major Product Offerings
7.4.4 Merck Brain Tumor Therapeutics Revenue in Global (2016-2021)
7.4.5 Merck Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Brain Tumor Therapeutics Major Product Offerings
7.5.4 AstraZeneca Brain Tumor Therapeutics Revenue in Global (2016-2021)
7.5.5 AstraZeneca Key News
7.6 GE Healthcare
7.6.1 GE Healthcare Corporate Summary
7.6.2 GE Healthcare Business Overview
7.6.3 GE Healthcare Brain Tumor Therapeutics Major Product Offerings
7.6.4 GE Healthcare Brain Tumor Therapeutics Revenue in Global (2016-2021)
7.6.5 GE Healthcare Key News
7.7 Hitachi Medical
7.7.1 Hitachi Medical Corporate Summary
7.7.2 Hitachi Medical Business Overview
7.7.3 Hitachi Medical Brain Tumor Therapeutics Major Product Offerings
7.4.4 Hitachi Medical Brain Tumor Therapeutics Revenue in Global (2016-2021)
7.7.5 Hitachi Medical Key News
7.8 Philips Healthcare
7.8.1 Philips Healthcare Corporate Summary
7.8.2 Philips Healthcare Business Overview
7.8.3 Philips Healthcare Brain Tumor Therapeutics Major Product Offerings
7.8.4 Philips Healthcare Brain Tumor Therapeutics Revenue in Global (2016-2021)
7.8.5 Philips Healthcare Key News
7.9 Novocure
7.9.1 Novocure Corporate Summary
7.9.2 Novocure Business Overview
7.9.3 Novocure Brain Tumor Therapeutics Major Product Offerings
7.9.4 Novocure Brain Tumor Therapeutics Revenue in Global (2016-2021)
7.9.5 Novocure Key News
7.10 DelMar Pharmaceuticals
7.10.1 DelMar Pharmaceuticals Corporate Summary
7.10.2 DelMar Pharmaceuticals Business Overview
7.10.3 DelMar Pharmaceuticals Brain Tumor Therapeutics Major Product Offerings
7.10.4 DelMar Pharmaceuticals Brain Tumor Therapeutics Revenue in Global (2016-2021)
7.10.5 DelMar Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Brain Tumor Therapeutics Market Opportunities & Trends in Global Market
Table 2. Brain Tumor Therapeutics Market Drivers in Global Market
Table 3. Brain Tumor Therapeutics Market Restraints in Global Market
Table 4. Key Players of Brain Tumor Therapeutics in Global Market
Table 5. Top Brain Tumor Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Brain Tumor Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Brain Tumor Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Brain Tumor Therapeutics Product Type
Table 9. List of Global Tier 1 Brain Tumor Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Tumor Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Brain Tumor Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Brain Tumor Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Brain Tumor Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Brain Tumor Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Brain Tumor Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Brain Tumor Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Brain Tumor Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Brain Tumor Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Brain Tumor Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Brain Tumor Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Brain Tumor Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Brain Tumor Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Brain Tumor Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Brain Tumor Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Brain Tumor Therapeutics Product Offerings
Table 32. Pfizer Brain Tumor Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis Brain Tumor Therapeutics Product Offerings
Table 35. Novartis Brain Tumor Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Roche Corporate Summary
Table 37. Roche Brain Tumor Therapeutics Product Offerings
Table 38. Roche Brain Tumor Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Merck Corporate Summary
Table 40. Merck Brain Tumor Therapeutics Product Offerings
Table 41. Merck Brain Tumor Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Brain Tumor Therapeutics Product Offerings
Table 44. AstraZeneca Brain Tumor Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. GE Healthcare Corporate Summary
Table 46. GE Healthcare Brain Tumor Therapeutics Product Offerings
Table 47. GE Healthcare Brain Tumor Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Hitachi Medical Corporate Summary
Table 49. Hitachi Medical Brain Tumor Therapeutics Product Offerings
Table 50. Hitachi Medical Brain Tumor Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. Philips Healthcare Corporate Summary
Table 52. Philips Healthcare Brain Tumor Therapeutics Product Offerings
Table 53. Philips Healthcare Brain Tumor Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Novocure Corporate Summary
Table 55. Novocure Brain Tumor Therapeutics Product Offerings
Table 56. Novocure Brain Tumor Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. DelMar Pharmaceuticals Corporate Summary
Table 58. DelMar Pharmaceuticals Brain Tumor Therapeutics Product Offerings
Table 59. DelMar Pharmaceuticals Brain Tumor Therapeutics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Brain Tumor Therapeutics Segment by Type
Figure 2. Brain Tumor Therapeutics Segment by Application
Figure 3. Global Brain Tumor Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Brain Tumor Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Brain Tumor Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Tumor Therapeutics Revenue in 2020
Figure 8. By Type - Global Brain Tumor Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Brain Tumor Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Brain Tumor Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Brain Tumor Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Brain Tumor Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Brain Tumor Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Brain Tumor Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Brain Tumor Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Brain Tumor Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Brain Tumor Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis Brain Tumor Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Roche Brain Tumor Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Merck Brain Tumor Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. AstraZeneca Brain Tumor Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. GE Healthcare Brain Tumor Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Hitachi Medical Brain Tumor Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Philips Healthcare Brain Tumor Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Novocure Brain Tumor Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. DelMar Pharmaceuticals Brain Tumor Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Pfizer
Novartis
Roche
Merck
AstraZeneca
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
DelMar Pharmaceuticals